Introducing much more of whey protein’s most effectful component
Beta-lactoglobulin (BLG) is the key component that makes whey protein such a high-quality protein source! Lacprodan® BLG-100 is 100%, pure BLG, offering a unique nutritional profile:
- 45%1 more leucine
- 26%1 more essential amino acids
Smaller servings, more high-quality protein
The ability to maintain muscle mass is necessary to ensure good outcomes during periods of critical illness, hospital admission and physical inactivity. At the same time, it is important to provide adequate overall nutrition for patients, or for the elderly suffering from reduced appetite. Consuming sufficient high-quality protein supports these aims.
Lacprodan® BLG-100 contains 45% more leucine than commercially available whey protein isolates1, supporting greater muscle protein synthesis to minimise loss of muscle mass2 and sustain physical mobility – and it has a low mineral content, too.
A new protein category is born
Lacprodan® BLG-100 is the newcomer alongside the established whey protein categories of concentrate, isolate and hydrolysate. It’s a unique new category that unlocks new opportunities within whey proteins for medical foods and beverages. Compared with established whey protein categories, Lacprodan® BLG-100 offers:
- An improved nutritional profile
- High leucine and essential amino acids content that can support the triggering and sustention of a robust muscle protein synthesis response in elderly and recovering patients
- More appealing taste to encourage appetite and improve overall compliance
- Low mineral content, especially low in phosphorus, making it suitable for kidney patients
This highly specialized ingredient is excellent for clear, ready-to-drink (RTD) or translucent, functional high-protein shot solutions. Lacprodan® BLG-100 enables very high protein concentrations (as high as 23%) in very small serving sizes. Thanks to minimal astringency, the ingredient delivers an appealing taste experience even at such high protein concentrations. These features make Lacprodan® BLG-100 a better match for the special needs of elderly patients with, or at risk of malnutrition, as well as others with increased protein needs.
New opportunities for medical markets
With Lacprodan® BLG-100, Arla Foods Ingredients is able to produce pure BLG at industrial scale, creating a big new opportunity for medical supplement manufacturers to expand their product range and offer powerful new solutions for elderly and patient populations.
Lacprodan® BLG-100 authorized as a novel food
As of 21 December 2022, Arla Foods Ingredients has received final authorization from the European Commission (EC) for its beta-lactoglobulin ingredient, Lacprodan® BLG-100.
The authorization states that Lacprodan® BLG-100 is safe and suitable to use in food products in the EU. The ingredient is suitable for a variety of applications within sports nutrition and in food for special medical purposes (FSMP).
Lacprodan® BLG-100 is Arla Foods Ingredients’ first product to receive approval under the new Novel Food Regulations (EU) 2015/2283.
1. Gorissen et al., 2018
2. Phillips, S.M., 2017
